Which Lymph Nodes Does Prostate Cancer Spread To First?

Many men are surprised to learn that prostate cancer may spread quietly before showing clear signs.

When this happens, one of the first places it tends to reach is the lymphatic system. These small but vital nodes act as filters, helping the body capture harmful cells before they travel further.

Understanding which lymph nodes are affected first is key to detecting the disease early and guiding treatment choices.

How prostate cancer moves through the lymphatic system

Prostate cancer may spread in stages, starting from the prostate gland and extending into nearby tissues.

The lymphatic system, made up of vessels and nodes, plays an important role in draining fluid and supporting immunity. However, these same pathways can carry cancer cells away from the prostate.

Once cancer cells break free from the primary tumour, they might enter the lymphatic vessels and reach nearby nodes. There, they can start forming secondary growths. This process helps doctors determine how advanced the cancer might be and what kind of care is most appropriate.

What are the first lymph nodes usually affected?

The pelvic lymph nodes are usually the first group affected by prostate cancer. These include the obturator, internal iliac, and external iliac nodes, located deep within the pelvis near the bladder and large blood vessels.

Among these, the obturator lymph nodes are most commonly involved first because they sit closest to the prostate. As the disease progresses, it may spread upward to the common iliac and para-aortic nodes, which lie higher in the abdomen.

During a pelvic lymph node dissection, specialists often check these areas to confirm whether cancer cells have spread. Identifying their involvement helps determine whether the cancer is locally advanced or has become metastatic.

Why lymph node involvement matters

Finding cancer in lymph nodes gives doctors a clearer picture of how the disease is behaving. If only a few nearby nodes are affected, treatment may still aim to remove or control the cancer locally. However, if the cancer has reached more distant nodes, it may indicate a more advanced stage that needs a wider treatment plan.

Detecting lymph node involvement early helps guide the use of surgery, radiotherapy, or hormone therapy. For example, if imaging shows that the pelvic nodes are affected, radiation may target these areas directly, often combined with hormone therapy for better outcomes.

It’s important to remember that lymph node spread doesn’t always mean the cancer can’t be managed successfully. With modern imaging and targeted treatment options, many patients continue to live well while managing their condition.

How doctors detect lymph node spread

Doctors use several methods to check whether prostate cancer has reached the lymph nodes. Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans are often the first steps, allowing specialists to see whether nodes appear enlarged.

In recent years, the Prostate-Specific Membrane Antigen (PSMA) PET scan has become a valuable tool. This advanced scan can highlight even small clusters of cancer cells that other imaging might miss. Sometimes, a biopsy or surgical removal of certain nodes is done to confirm whether cancer is present.

What happens when lymph nodes test positive?

When prostate cancer reaches the lymph nodes, it’s referred to as lymph node-positive prostate cancer. Treatment depends on how many nodes are affected and where they’re located.

For localised spread, surgery or targeted radiotherapy might be suitable. If the cancer has moved to distant nodes or bones, doctors may recommend systemic treatments such as hormone therapy or chemotherapy.

Even with node-positive results, many men respond well to combination therapies that manage symptoms and slow disease progression. Your specialist may suggest ongoing monitoring, as the rate and pattern of spread can vary. Personalised treatment remains central to improving long-term outcomes.

Taking care of your health during treatment

When dealing with prostate cancer that’s spread to the lymph nodes, supporting your overall health is vital. Staying active, eating well, and maintaining emotional balance can help your body cope with treatment. Communicate openly with your care team about any side effects or concerns so they can support you fully.

Every case is unique, and your treatment plan should reflect your personal health, age, and cancer stage. Specialist urology clinics, like Urocare London, focus on precise diagnosis and tailored care to achieve the best outcomes while maintaining quality of life.

Finding confidence in early action

Learning that prostate cancer has reached the lymph nodes can feel unsettling, but it’s not the end of effective care.

With accurate imaging, early diagnosis, and modern treatments, doctors can create a clear, personalised plan to manage the condition.

Maneesh Ghei

Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.